Clinical conditions and treatment requirements for long‐term survival among hepatitis B‐related hepatocellular carcinoma initially treated with chemoembolization

by Zhen‐Xin Chen, Zhi‐Wei Jian, Xi‐Wen Wu, Jun‐Cheng Wang, Jing‐Yuan Peng, Xiang‐Ming Lao
Published 2019-09-01

Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2‐Hippo signaling pathway

by Yi Zhang, Long‐Jun He, Lin‐Lin Huang, Sheng Yao, Nan Lin, Ping Li, Hui‐Wen Xu, Xi‐Wen Wu, Jian‐Liang Xu, Yi Lu, Yan‐Jie Li, Sen‐Lin Zhu
Published 2021-08-01